Differentiation Syndrome
7 drugs689 FAERS reportsMedDRA PT
GET
/api/v1/reaction/differentiation-syndromeReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
Drugs reporting Differentiation Syndrome (7)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Ziftomenib421%
- 2Revumenib314.5%
- 3Ivosidenib864.5%
- 4Arsenic2204.2%
- 5Arsenic Trioxide2144.2%
- 6Gilteritinib912.4%
- 7Enasidenib431.3%
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
- Electrocardiogram Qt Prolonged6 shared · 0.17
- Full Blood Count Decreased2 shared · 0.15
- Acute Myeloid Leukaemia2 shared · 0.06
- Neutrophil Count Decreased2 shared · 0.04
- White Blood Cell Count Decreased3 shared · 0.03
- Haemoglobin Decreased3 shared · 0.03
- Platelet Count Decreased5 shared · 0.03
- Peripheral Swelling2 shared · 0.02
- Product Use Issue3 shared · 0.02
- Infection2 shared · 0.01
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.